BACKGROUND: Pulmonary arterial hypertension (PAH) and breast cancer disproportionately affect women. BMPR2 (bone morphogenetic protein receptor type 2) mutations, the most common genetic cause of heritable PAH, also exert tumor-suppressive functions, but their role in linking these diseases remains unclear. METHODS: We combined bioinformatic, epidemiologic, and experimental approaches. Public cancer datasets were mined for BMPR2 alterations. In vivo, mammary tumor development and pulmonary hemodynamics were assessed in female Bmpr2(+/
- Toro, V.
- Mougin, M.
- Brossat, C.
- Jambon-Barbara, C.
- Hlavaty, A.
- Guay, C. A.
- El Kabbout, R.
- Bilodeau, C.
- Grobs, Y.
- Martineau, S.
- Breuils-Bonnet, S.
- Abi-Sleimen, A.
- Ruffenach, G.
- Boucherat, O.
- Bisserier, M.
- Provencher, S.
- Bonnet, S.
- Montani, D.
- Khouri, C.
- Potus, F.
Keywords
- Bmpr2
- animal model
- breast cancer
- inflammation
- pulmonary hypertension
- tumors